Molecular pathways and therapeutic targets in lung cancer
1.1. RECEPTOR TYROSINE KINASES (RTKs) RTKs are involved in different types of lung cancer at different frequencies, but have attracted a lot of interest because there are targeted therapies for activated RTKs approved or fairly advanced in clinical develo...